{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T20:05:53Z","timestamp":1776024353051,"version":"3.50.1"},"reference-count":31,"publisher":"Frontiers Media SA","funder":[{"name":"7th European Community Framework Program","award":["IIF-GA-2011-300197"],"award-info":[{"award-number":["IIF-GA-2011-300197"]}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2016.00457","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T23:11:12Z","timestamp":1475709072000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models"],"prefix":"10.3389","volume":"10","author":[{"given":"Alba","family":"Di Pardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11682-011-9121-8","article-title":"Diffusion tensor imaging in Huntington's disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits","volume":"5","author":"Bohanna","year":"2011","journal-title":"Brain Imaging Behav."},{"key":"B2","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1093\/cercor\/bhr360","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B3","doi-asserted-by":"publisher","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","article-title":"Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice","volume":"285","author":"Bradford","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B4","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease","volume":"47","author":"Ciarmiello","year":"2006","journal-title":"J. Nucl. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1471-4159.2010.06964.x","article-title":"Cerebellar lipid differences between R6\/1 transgenic mice and humans with Huntington's disease","volume":"115","author":"Denny","year":"2010","journal-title":"J. Neurochem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.nbd.2007.05.003","article-title":"Glycolipid and ganglioside metabolism imbalances in Huntington's disease","volume":"27","author":"Desplats","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/cercor\/bhr360","article-title":"Multimodal MRI analysis of the corpus callosum reveals white matter differences in presymptomatic and early Huntington's disease","volume":"22","author":"Di Paola","year":"2012","journal-title":"Cereb. Cortex"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1002\/hbm.22391","article-title":"MRI measures of corpus callosum iron and myelin in early Huntington's disease","volume":"35","author":"Di Paola","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","article-title":"FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease","volume":"23","author":"Di Pardo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.nicl.2013.03.001","article-title":"TRACK-H, investigator group. Reduced functional brain connectivity prior to and after disease onset in Huntington's disease","volume":"2","author":"Dumas","year":"2013","journal-title":"Neuroimage Clin."},{"key":"B11","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1212\/01.WNL.0000138434.68093.67","article-title":"In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease","volume":"63","author":"Fennema-Notestine","year":"2004","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1093\/hmg\/ddv248","article-title":"Analysis of YFP(J16)-R6\/2 reporter mice and postmortem brains reveal early pathology and increased vulnerability of callosal axons in Huntington's disease","volume":"24","author":"Gatto","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1471-4159.2010.06672.x","article-title":"Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features","volume":"113","author":"Han","year":"2010","journal-title":"J. Neurochem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12035-009-8097-5","article-title":"Targeting glial cells to elucidate the pathogenesis of Huntington's disease","volume":"41","author":"Hsiao","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.neuron.2015.02.026","article-title":"Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes","volume":"85","author":"Huang","year":"2015","journal-title":"Neuron"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1093\/hmg\/ddv016","article-title":"Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease","volume":"24","author":"Jin","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/jnr.490270432","article-title":"Neurobiology of human oligodendrocytes in culture","volume":"27","author":"Kim","year":"1990","journal-title":"J. Neurosci. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuroimage.2008.02.019","article-title":"Cortical thickness measured from MRI in the YAC128 mouse model of Huntington's disease","volume":"41","author":"Lerch","year":"2008","journal-title":"Neuroimage"},{"key":"B19","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","article-title":"Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice","volume":"21","author":"Li","year":"2001","journal-title":"J. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1523\/JNEUROSCI.6348-09.2010","article-title":"Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1","volume":"30","author":"Maglione","year":"2010","journal-title":"J. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/B978-0-12-381328-2.00013-4","article-title":"Huntington's disease: clinical presentation and treatment","volume":"98","author":"Novak","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.febslet.2009.12.010","article-title":"Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction","volume":"589","author":"Posse de Chaves","year":"2010","journal-title":"FEBS Lett."},{"key":"B23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.nbd.2014.01.013","article-title":"White matter connectivity reflects clinical and cognitive status in Huntington's disease","volume":"65","author":"Poudel","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1016\/j.neuroimage.2009.10.015","article-title":"Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical \u201cdisconnection.\u201d","volume":"49","author":"Rosas","year":"2010","journal-title":"Neuroimage"},{"key":"B25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbalip.2008.01.004","article-title":"Functions of sphingolipid metabolism in mammals\u2013lessons from genetic defects","volume":"1781","author":"Sabourdy","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.febslet.2009.10.011","article-title":"Brain gangliosides in axon-myelin stability and axon regeneration","volume":"584","author":"Schnaar","year":"2010","journal-title":"FEBS Lett."},{"key":"B27","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.96.13.7532","article-title":"Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects","volume":"96","author":"Sheikh","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.nbd.2015.01.002","article-title":"Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease","volume":"76","author":"Southwell","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","article-title":"Peroxisome-proliferator-activated receptor gamma coactivator 1 \u03b1 contributes to dysmyelination in experimental models of Huntington's disease","volume":"31","author":"Xiang","year":"2011","journal-title":"J. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1073\/pnas.0407785102","article-title":"Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions","volume":"102","author":"Yamashita","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T05:08:05Z","timestamp":1568437685000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2016.00457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,6]]},"references-count":31,"URL":"https:\/\/doi.org\/10.3389\/fnins.2016.00457","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,6]]}}}